These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7121130)

  • 1. Contributions of vasoactive substances in cases of chronic arteriosclerotic occlusion in the lower extremities.
    Numata M
    Methods Find Exp Clin Pharmacol; 1982; 4(3):199-202. PubMed ID: 7121130
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of Sadamin on lipid metabolism in patients with obliterative arteriosclerosis of lower limbs].
    Kiersnowska B; Bielawiec M; Lukjan H; Grabowski R; Korfel B
    Pol Tyg Lek; 1972 Jan; 27(4):133-5. PubMed ID: 5010169
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacodynamic study on nicotinic acid and of one of its higher homologs (3-pyridyl acetic acid) in obliterative arteriopathies of the extremities].
    Spanò G; Saponaro A; Giordano G; Verde AM; Cosentino F; Dagianti A
    Boll Soc Ital Cardiol; 1967; 12(2):148-53. PubMed ID: 5606866
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of niceritrol (pentaerythritoltetranicotinate) on experimental atherosclerosis in cholesterol-fed rabbits at different levels of plasma cholesterol.
    Brattsand R
    Acta Pharmacol Toxicol (Copenh); 1975 Jan; 36(1):39-55. PubMed ID: 1173722
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects on lipids, blood viscosity and platelet aggregation of combined use of niceritrol (Perycit) and a low dose of acetylsalicylic acid.
    Hamazaki T; Hasunuma K; Kobayashi S; Shishido H; Yano S
    Atherosclerosis; 1985 Apr; 55(1):107-13. PubMed ID: 4004983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of nicotinic acid on the blood circulation disorders of the lower extremities].
    Kirsch J; Kirsch J
    Z Allgemeinmed; 1964 Dec; 40(35):1527-30. PubMed ID: 5889482
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypolipemic therapy of occlusive arteriosclerosis of the lower extremities. Short-term biochemical results].
    Lasso M; García Merlo G; Medarde A
    Angiologia; 1973; 25(1):43-8. PubMed ID: 4685110
    [No Abstract]   [Full Text] [Related]  

  • 8. [Selected indicators of lipid metabolism in patients with chronic arteriosclerotic ischemia of the lower limbs].
    Maruszyński M; Bartnikowska E
    Wiad Lek; 1985 Jul; 38(14):1005-12. PubMed ID: 4072189
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute effects on plasma lipids in the rat of a new long-acting nicotinic acid derivative: LG 13979.
    Subissi A; Criscuoli M; Biagi M; Murmann W
    J Pharm Pharmacol; 1983 Sep; 35(9):571-5. PubMed ID: 6138406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution of occlusion arteriosclerosis of lower extremities in young males (author's transl)].
    Brücknerová O
    Cas Lek Cesk; 1978 Mar; 117(9):260-4. PubMed ID: 647740
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemical problems of arteriosclerosis and vascular occlusion caused by arteriosclerosis].
    Kresse H
    Med Monatsschr; 1969 Apr; 23(4):166-71. PubMed ID: 5801516
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of arteriosclerotic peripheral vascular diseases with ciclonicate].
    Gregoratti L; Crespi B; Groothold G; Fuligni E; Ghiringhelli L
    Minerva Cardioangiol; 1982 Nov; 30(11):659-68. PubMed ID: 7155375
    [No Abstract]   [Full Text] [Related]  

  • 13. [Niconacid increases blood circulation--decreases blood lipid level].
    Heynen U
    Z Allgemeinmed; 1970 Sep; 46(25):1264-5. PubMed ID: 5522715
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experiences with alpha-tocopherol micotinate in the treatment of arteriosclerosis].
    Dobrowolski L
    Fortschr Med; 1972 Sep; 90(25):913-6. PubMed ID: 4642946
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reconstructive treatment of arteriosclerotic obliterations of arteries in the lower extremities].
    Masurka V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1966; 9(5):Suppl 5:579-95. PubMed ID: 5227566
    [No Abstract]   [Full Text] [Related]  

  • 16. [The therapeutic problem of arteriosclerotic arteriopathies of the lower extremities].
    Gatta L; Montemurro G
    Minerva Med; 1980 Apr; 71(16):1173-9. PubMed ID: 7375035
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of different dose regimens of niceritrol of serum lipid concentrations in man.
    Rössner S; Olsson AG; Orö L
    Acta Med Scand; 1976; 200(4):269-71. PubMed ID: 983794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some cardiovascular effects of LG 13979: comparison with nicotinic acid and other nicotinic acid derivatives.
    Subissi A; Bachi M; Brunori P
    J Pharm Pharmacol; 1983 Sep; 35(9):612-4. PubMed ID: 6138419
    [No Abstract]   [Full Text] [Related]  

  • 19. [Functional capacity of the coronary vessels in patients with arteriosclerotic changes in the lower limbs].
    Pardela M; Jagielski K; Hermasz K; Szczechowski K
    Przegl Lek; 1982; 39(12):811-4. PubMed ID: 7167648
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intra-arterial drug injections in arteriosclerosis of the lower extremities].
    Napierala M; Mackiewicz Z; Zapalski S
    Pol Przegl Chir; 1974 Sep; 46(9):1215-9. PubMed ID: 4409898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.